Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" process.

Sun H, Ehlhardt WJ, Kulanthaivel P, Lanza DL, Reilly CA, Yost GS.

J Pharmacol Exp Ther. 2007 Aug;322(2):843-51. Epub 2007 May 14.

PMID:
17502430
2.

Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells.

Thomas KC, Sabnis AS, Johansen ME, Lanza DL, Moos PJ, Yost GS, Reilly CA.

J Pharmacol Exp Ther. 2007 Jun;321(3):830-8. Epub 2007 Mar 1.

PMID:
17332266
3.

Effects of the differentiated keratinocyte phenotype on expression levels of CYP1-4 family genes in human skin cells.

Du L, Neis MM, Ladd PA, Lanza DL, Yost GS, Keeney DS.

Toxicol Appl Pharmacol. 2006 Jun 1;213(2):135-44. Epub 2005 Nov 22.

PMID:
16307767
4.
5.

Sp1 and Sp3 regulate basal transcription of the human CYP2F1 gene.

Wan J, Carr BA, Cutler NS, Lanza DL, Hines RN, Yost GS.

Drug Metab Dispos. 2005 Aug;33(8):1244-53. Epub 2005 Apr 28.

PMID:
15860659
6.

Bioactivation of 1,1-dichloroethylene to its epoxide by CYP2E1 and CYP2F enzymes.

Simmonds AC, Reilly CA, Baldwin RM, Ghanayem BI, Lanza DL, Yost GS, Collins KS, Forkert PG.

Drug Metab Dispos. 2004 Sep;32(9):1032-9.

PMID:
15319346
7.

Inflammatory cytokines and cell death in BEAS-2B lung cells treated with soil dust, lipopolysaccharide, and surface-modified particles.

Veranth JM, Reilly CA, Veranth MM, Moss TA, Langelier CR, Lanza DL, Yost GS.

Toxicol Sci. 2004 Nov;82(1):88-96. Epub 2004 Aug 13.

8.

Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors.

Reilly CA, Taylor JL, Lanza DL, Carr BA, Crouch DJ, Yost GS.

Toxicol Sci. 2003 May;73(1):170-81.

9.

Association of 3-methyleneindolenine, a toxic metabolite of 3-methylindole, with acute interstitial pneumonia in feedlot cattle.

Loneragan GH, Gould DH, Mason GL, Garry FB, Yost GS, Lanza DL, Miles DG, Hoffman BW, Mills LJ.

Am J Vet Res. 2001 Oct;62(10):1525-30.

PMID:
11592314
10.

Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome p450 enzymes.

Lanza DL, Yost GS.

Drug Metab Dispos. 2001 Jul;29(7):950-3.

PMID:
11408359
11.

Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells.

Lanza DL, Code E, Crespi CL, Gonzalez FJ, Yost GS.

Drug Metab Dispos. 1999 Jul;27(7):798-803.

PMID:
10383923
12.

Evidence supporting the formation of 2,3-epoxy-3-methylindoline: a reactive intermediate of the pneumotoxin 3-methylindole.

Skordos KW, Skiles GL, Laycock JD, Lanza DL, Yost GS.

Chem Res Toxicol. 1998 Jul;11(7):741-9.

PMID:
9671536
13.

Supplemental Content

Loading ...
Support Center